SCHEMBL17848138

SCHEMBL17848138

Nc1n[nH]c2cc(Br)c(Cc3cc(F)cc(F)c3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 4/20 0.41
PDPK1 O15530 2/20 0.41
NTRK1 P04629 11/20 0.39
MKNK2 Q9HBH9 3/20 0.37
MAPK1 P28482 2/20 0.37
MKNK1 Q9BUB5 1/20 0.37
CDC7 O00311 2/20 0.34
ROCK2 O75116 2/20 0.34
MAP4K4 O95819 2/20 0.34
PRKACA P17612 2/20 0.34
CDK2 P24941 2/20 0.34
GSK3B P49841 2/20 0.34
AURKB Q96GD4 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
PLK4 O00444 1/20 0.34
MAPK13 O15264 1/20 0.34
DAPK3 O43293 1/20 0.34
DYRK3 O43781 1/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17848108 0.88 MAPK1 (0.47) JAK2PDPK1NTRK1MKNK2MAPK1
SCHEMBL17848143 0.76 FGFR1 (0.43) JAK2PDPK1NTRK1MKNK2MKNK1
SCHEMBL17848223 0.75 NTRK1 (0.51) NTRK1GSK3BAURKBPLK4DAPK3
SCHEMBL30451203 0.75 NTRK1 (0.66) JAK2PDPK1NTRK1AURKB
SCHEMBL3510229 0.75 NTRK1 (0.66) JAK2PDPK1NTRK1AURKB
SCHEMBL17848137 0.72 MAPK1 (0.37) JAK2NTRK1MKNK2MAPK1MKNK1
SCHEMBL6478729 0.72 PDPK1 (0.59) JAK2PDPK1CDK2GSK3BAURKB
SCHEMBL29415511 0.67 NTRK1 (0.52) JAK2PDPK1NTRK1MKNK2MAPK1
SCHEMBL29415512 0.67 NTRK1 (0.52) JAK2PDPK1NTRK1MKNK2MAPK1
SCHEMBL3512493 0.67 NTRK1 (0.52) JAK2PDPK1NTRK1MKNK2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336707-B2 Heterocyclic derivatives modulating activity of certain protein kinases EUDENDRON S.R.L. (IT) 2019-07-02 US disclosed
US-10336707-B2 Heterocyclic derivatives modulating activity of certain protein kinases EUDENDRON S.R.L. (IT) 2019-07-02 US disclosed
EP-3233840-B1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES EUDENDRON S R L (IT) 2018-11-21 EP disclosed
US-20180118691-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES UNVERSITA' DEGLI STUDI DI MILANO (IT) 2018-05-03 US disclosed
US-20180118691-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES UNVERSITA' DEGLI STUDI DI MILANO (IT) 2018-05-03 US disclosed
EP-3233840-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES Eudendron S.r.l. (IT) 2017-10-25 EP disclosed
WO-2016096709-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES EUDENDRON S.R.L. (IT) 2016-06-23 WO disclosed
WO-2016096709-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES EUDENDRON S.R.L. (IT) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118691-A1 HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES MAP4K2, MAP3K20, MAPKAPK2 JAK2 394/4885PDPK1 46/4885NTRK1 561/4885
US-10336707-B2 Heterocyclic derivatives modulating activity of certain protein kinases MAP4K2, MAP3K20, MAPKAPK2 JAK2 394/4885PDPK1 46/4885NTRK1 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.